Capital Fund Management (CFM)
IONS icon

Capital Fund Management (CFM)’s Ionis Pharmaceuticals IONS Stock Holding History

Capital Fund Management (CFM)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,500
Closed -$270K – 1920
2019
Q3 		$270K Sell
4,500
-23,000
-84% -$1.5M ﹤0.01% 1474
2019
Q2 		$1.77M Buy
27,500
+21,300
+344% +$1.51M 0.02% 837
2019
Q1 		$503K Buy
+6,200
New +$400K ﹤0.01% 1252
2016
Q2 		– Sell
-26,900
Closed -$1.09M – 1639
2016
Q1 		$1.09M Buy
26,900
+22,000
+449% +$894K 0.01% 875
2015
Q4 		$303K Buy
+4,900
New +$264K ﹤0.01% 1303
2015
Q3 		– Sell
-10,500
Closed -$604K – 1519
2015
Q2 		$604K Sell
10,500
-15,500
-60% -$986K 0.01% 1015
2015
Q1 		$1.66M Buy
26,000
+19,600
+306% +$1.33M 0.02% 630
2014
Q4 		$395K Buy
+6,400
New +$316K ﹤0.01% 1230
2014
Q3 		– Sell
-9,300
Closed -$320K – 1651
2014
Q2 		$320K Buy
+9,300
New +$293K ﹤0.01% 1400
2013
Q4 		– Sell
-16,200
Closed -$608K – 1733
2013
Q3 		$608K Sell
16,200
-11,300
-41% -$338K 0.01% 1080
2013
Q2 		$739K Buy
+27,500
New +$585K 0.01% 879

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital Fund Management (CFM)'s IONS Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its Ionis Pharmaceuticals (IONS) stake by 132% in Q2 2026, buying an estimated $14.1M and bringing the position to 329,554 shares worth $26.1M. The position accounts for 0.12% of the portfolio, ranked #215.

Capital Fund Management (CFM) first reported a position in IONS in Q2 2013 and has held it in 33 quarters since. The position peaked at $26.8M in Q2 2015. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Capital Fund Management (CFM) held 329,554 shares of Ionis Pharmaceuticals worth $26.1M as of Q2 2026.
  • Capital Fund Management (CFM) bought 187,353 Ionis Pharmaceuticals shares in Q2 2026, an estimated $14.1M.
  • Ionis Pharmaceuticals made up 0.12% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #215 holding.
  • Capital Fund Management (CFM) first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
  • Capital Fund Management (CFM)'s Ionis Pharmaceuticals position peaked at $26.8M in Q2 2015.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.